Upcoming Ph 2 readouts in Q1 2024…
$Cellectar BioSciences (CLRB.US)$ Phase 2
$Regenxbio (RGNX.US)$ Phase 2
$Leap Therapeutics (LPTX.US)$ Phase 2
$4D Molecular Therapeutics (FDMT.US)$ Phase 2
$Adverum Biotechnologies (ADVM.US)$ Phase 2
$Denali Therapeutics (DNLI.US)$ Phase 2
$EyePoint Pharmaceuticals (EYPT.US)$ Phase 2
$Xencor (XNCR.US)$ Phase 2
$Harmony Biosciences (HRMY.US)$ Phase 2
$Alnylam Pharmaceuticals (ALNY.US)$ Phase 2
$Disc Medicine (IRON.US)$ Phase 2
$Atea Pharmaceuticals (AVIR.US)$ Phase 2
$Allakos (ALLK.US)$ Phase 2
$Fusion Pharmaceuticals (FUSN.US)$ Phase 2
$Spruce Biosciences (SPRB.US)$ Phase 2 (2)
$Aslan Pharmaceuticals (ASLN.US)$ Phase 2
$TFF Pharmaceuticals (TFFP.US)$ Phase 2 (2)
$Roivant Sciences (ROIV.US)$ Phase 2
$Cogent Biosciences (COGT.US)$ Phase 2
$Clene (CLNN.US)$ Phase 2 (2)
$Ironwood Pharmaceuticals (IRWD.US)$ Phase 2
$MoonLake Immunotherapeutics (MLTX.US)$ Phase 2
$Altimmune (ALT.US)$ Phase 2
$G1 Therapeutics (GTHX.US)$ Phase 2
$Kiniksa Pharmaceuticals International (KNSA.US)$ Phase 2
$Larimar Therapeutics (LRMR.US)$ Phase 2
$Vir Biotechnology (VIR.US)$ Phase 2
$Ventyx Biosciences (VTYX.US)$ Phase 2 (2)
$HOOKIPA Pharma (HOOK.US)$ Phase 2
$argenx SE (ARGX.US)$ Phase 2
$ARS Pharmaceuticals (SPRY.US)$ Phase 2
$Innate Pharma (IPHA.US)$ Phase 2
$AC Immune (ACIU.US)$ Phase 2 (2)
$Regenxbio (RGNX.US)$ Phase 2
$Leap Therapeutics (LPTX.US)$ Phase 2
$4D Molecular Therapeutics (FDMT.US)$ Phase 2
$Adverum Biotechnologies (ADVM.US)$ Phase 2
$Denali Therapeutics (DNLI.US)$ Phase 2
$EyePoint Pharmaceuticals (EYPT.US)$ Phase 2
$Xencor (XNCR.US)$ Phase 2
$Harmony Biosciences (HRMY.US)$ Phase 2
$Alnylam Pharmaceuticals (ALNY.US)$ Phase 2
$Disc Medicine (IRON.US)$ Phase 2
$Atea Pharmaceuticals (AVIR.US)$ Phase 2
$Allakos (ALLK.US)$ Phase 2
$Fusion Pharmaceuticals (FUSN.US)$ Phase 2
$Spruce Biosciences (SPRB.US)$ Phase 2 (2)
$Aslan Pharmaceuticals (ASLN.US)$ Phase 2
$TFF Pharmaceuticals (TFFP.US)$ Phase 2 (2)
$Roivant Sciences (ROIV.US)$ Phase 2
$Cogent Biosciences (COGT.US)$ Phase 2
$Clene (CLNN.US)$ Phase 2 (2)
$Ironwood Pharmaceuticals (IRWD.US)$ Phase 2
$MoonLake Immunotherapeutics (MLTX.US)$ Phase 2
$Altimmune (ALT.US)$ Phase 2
$G1 Therapeutics (GTHX.US)$ Phase 2
$Kiniksa Pharmaceuticals International (KNSA.US)$ Phase 2
$Larimar Therapeutics (LRMR.US)$ Phase 2
$Vir Biotechnology (VIR.US)$ Phase 2
$Ventyx Biosciences (VTYX.US)$ Phase 2 (2)
$HOOKIPA Pharma (HOOK.US)$ Phase 2
$argenx SE (ARGX.US)$ Phase 2
$ARS Pharmaceuticals (SPRY.US)$ Phase 2
$Innate Pharma (IPHA.US)$ Phase 2
$AC Immune (ACIU.US)$ Phase 2 (2)
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
kumarpentakota : where did you get this data
Joy Boy or Bringer : wonderful, Meltyy... thank you...
Trytosaveabit : Thank you for sharing! GL![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
102415025 : Wait for the good news later
73103485 : thank you you are super
JuliaBiswas : $Ventyx Biosciences (VTYX.US)$ 22 Feb 2024 will officially announce positive Phase 2 results
IDKWTFIMDOING : @Boxman
Boxman : Yo !! Look at that list! Thanks for the heads up IDKWTFIMDOING and Meltyy
IDKWTFIMDOING : @Cornilias silkshire